List of Table

List of Tables
Table 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Aloxi (Palonosetron)
Table 3. Key Players of Kytril (Granisetron)
Table 4. Key Players of Emend (Aprepitant)
Table 5. Key Players of Others
Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2017-2022)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2023-2028)
Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
Table 15. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players (2017-2022)
Table 18. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2021)
Table 19. Ranking of Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
Table 23. Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. GlaxoSmithKline Company Detail
Table 44. GlaxoSmithKline Business Overview
Table 45. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 46. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 47. GlaxoSmithKline Recent Development
Table 48. Helsinn Company Detail
Table 49. Helsinn Business Overview
Table 50. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 51. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 52. Helsinn Recent Development
Table 53. Heron Therapeutics Company Detail
Table 54. Heron Therapeutics Business Overview
Table 55. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 56. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 57. Heron Therapeutics Recent Development
Table 58. Merck & Co Company Detail
Table 59. Merck & Co Business Overview
Table 60. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 61. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 62. Merck & Co Recent Development
Table 63. Tesaro Company Detail
Table 64. Tesaro Business Overview
Table 65. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 66. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 67. Tesaro Recent Development
Table 68. Acacia Pharma Company Detail
Table 69. Acacia Pharma Business Overview
Table 70. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 71. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 72. Acacia Pharma Recent Development
Table 73. Aphios Company Detail
Table 74. Aphios Business Overview
Table 75. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 76. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 77. Aphios Recent Development
Table 78. Barr Laboratories Company Detail
Table 79. Barr Laboratories Business Overview
Table 80. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 81. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 82. Barr Laboratories Recent Development
Table 83. Baxter Healthcare Company Detail
Table 84. Baxter Healthcare Business Overview
Table 85. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 86. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 87. Baxter Healthcare Recent Development
Table 88. Eisai Company Detail
Table 89. Eisai Business Overview
Table 90. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 91. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 92. Eisai Recent Development
Table 93. Especificos Stendhal Company Detail
Table 94. Especificos Stendhal Business Overview
Table 95. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 96. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 97. Especificos Stendhal Recent Development
Table 98. F.Hoffmann La Roche Company Detail
Table 99. F.Hoffmann La Roche Business Overview
Table 100. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 101. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 102. F.Hoffmann La Roche Recent Development
Table 103. Mundipharma Company Detail
Table 104. Mundipharma Business Overview
Table 105. Mundipharma Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 106. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 107. Mundipharma Recent Development
Table 108. Mylan Pharmaceuticals Company Detail
Table 109. Mylan Pharmaceuticals Business Overview
Table 110. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 111. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 112. Mylan Pharmaceuticals Recent Development
Table 113. OPKO Health Company Detail
Table 114. OPKO Health Business Overview
Table 115. OPKO Health Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 116. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 117. OPKO Health Recent Development
Table 118. Orchid Healthcare Company Detail
Table 119. Orchid Healthcare Business Overview
Table 120. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting TreatmentProduct
Table 121. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022) & (US$ Million)
Table 122. Orchid Healthcare Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources

List of Figure

List of Figures
Figure 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2021 VS 2028
Figure 2. Aloxi (Palonosetron) Features
Figure 3. Kytril (Granisetron) Features
Figure 4. Emend (Aprepitant) Features
Figure 5. Others Features
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application in 2021 & 2028
Figure 7. Acute Nausea and Vomitting Treatment Case Studies
Figure 8. Delayed Nausea and Vomitting Treatment Case Studies
Figure 9. Anticipatory Nausea and Vomitting Treatment Case Studies
Figure 10. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2021
Figure 15. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2021
Figure 17. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2017-2028)
Figure 19. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2017-2028)
Figure 23. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2017-2028)
Figure 31. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 46. Helsinn Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 47. Heron Therapeutics Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 48. Merck & Co Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 49. Tesaro Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 50. Acacia Pharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 51. Aphios Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 52. Barr Laboratories Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 53. Baxter Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 54. Eisai Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 55. Especificos Stendhal Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 56. F.Hoffmann La Roche Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 57. Mundipharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 58. Mylan Pharmaceuticals Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 59. OPKO Health Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 60. Orchid Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed